Welcome to the following new members who have recently joined G-I-N. This page will be continually updated as new members join.
Sansom Institute for Health Research - University of South Australia
Led by renowned oncologist, cancer researcher and bioethicist Professor Ian Olver, the Sansom Institute for Health Research brings together leading researchers with the key aims of intervening early to prevent illness, improving health systems and services, creating more effective therapies, and advancing health equality.
Named after eminent Australian pharmacist Emeritus Professor Lloyd Sansom AO, the Sansom Institute encompasses a unique breadth of research that extends across the entire health spectrum. More than 250 members and 200 PhD students collaborate across a diverse range of cutting edge projects, with an annual research income of over $20m. We have many valued national and international collaborations, and the institute currently collaborates with around 120 institutions in 22 countries.
The Sansom has an emphasis on 6 broad themes in health: cancer, healthy lifestyles, neuroscience and mental health, pharmaceuticals and population health. Working within and across these themes are around 30 different concentrations producing innovative research linked to better health; areas of expertise are diverse and include allied health, musculoskeletal health and bone growth, cell biology, the early origins of adult health, epilepsy, medicines and vaccines development, anthropometry and sports science, health and use of time, health economics, microbiology and infectious disease, evolutionary physiology of the lung, mosquito-borne disease, nursing and midwifery, mental health and substance use, nutrition, neuroscience, public health, medicines policy, epidemiology, therapeutics and pharmaceutical science.
Underpinning all of these themes is a commitment to evidence-based practice in health - producing the primary and secondary evidence to guide clinicians in quality, equitable health service delivery.
For more information visit https://www.methodologyhubs.mrc.ac.uk/
Dr Albert Martirosyan
Albert is currently working as a surgeon in the Department of Cardiovascular Surgery at the Erebouni Medical Center and is the founder and the vice president of the Armenian Association of Specialists in Evidence-Based Medicine. He advises researchers and doctors on biostatistics and evidence-based medicine, lectures to students and researchers, participates in the reviewing of the guidelines on the AGREE II.
Dr Billy M. Tsima, MMed, M.S.C.E
Billy is a Family Physician and Senior Lecturer at the University of Botswana, Faculty of Medicine. He holds a Bachelor of Medicine degree from Newcastle University, Australia. He completed his Family Medicine training with the University of Stellenbosch, South African. Billy holds a Masters of Science degree in Clinical Epidemiology from the University of Pennsylvania, USA. He has worked with the Botswana Ministry of Health to develop Clinical Practice Guidelines for primary healthcare practitioners in Botswana.
Elizabeth Matovinovic MSc, PhD
Elizabeth is an independent consultant living in the US and affiliated with the Faculty of Medicine at Chiang Mai University in Thailand. Elizabeth has worked in academia, government and in the pharmaceutical industry specialising in global phase IV real world surveillance studies.
She is a Cochrane author and GRADE member with current projects related to the philosophy of evidence based medicine. Elizabeth joined G-I-N to network with guidelines people across the globe and perhaps someday begin or join a collaboration researching low cost or regionally appropriate alternatives to gold standard treatments.
MRC Hubs for Trials Methodology Research Network
The MRC Hubs for Trials Methodology Research Network comprises five Hubs working together as a Network to make a real difference to improve the quality of trials and, ultimately, patient care. The HTMR Network promotes and encourages collaborative methodological research relevant to trials, with the aim of accelerating implementation of the most effective and appropriate methods.
The Hubs for Trials Methodology Research (HTMR) were first established by the MRC in 2009 to create a UK-wide regionally distributed research resource to improve the design, conduct, analysis, interpretation, and reporting of clinical trials. The HTMR Network was created to add value by enhancing the activities of the individual Hubs, strengthening the methodological research further, and aiding dissemination and education relating to good methods in clinical trials. Our activities include:
- Facilitating collaborative inter-Hub projects
- Supporting training in new methods
- Encouraging new collaborations inside and outside the Network through its Working Groups
- Strengthening communication across the Hubs and with the wider methodology and trials community
- And acting as a central contact point between key stakeholders and the Hubs.
For more information visit https://www.methodologyhubs.mrc.ac.uk/
Professor Dafin F. Muresanu, MD, PhD, MBA, FANA
Professor of Neurology, Senior Neurologist, Chairman of the Neurosciences Department, Faculty of Medicine, University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj-Napoca, President of the Romanian Society of Neurology, President of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN), member of the Academy of Medical Sciences, Romania, secretary of its Cluj Branch. He is also member of 13 scientific international societies (being member of the American Neurological Association (ANA) - Fellow of ANA (FANA) since 2012) and 7 national ones, being part of the executive board of most of these societies.
Professor Dafin F. Muresanu is a specialist in Leadership and Management of Research and Health Care Systems (specialization in Management and Leadership, Arthur Anderson Institute, Illinois, USA, 1998 and several international courses and training stages in Neurology, research, management and leadership). Professor Dafin F. Muresanu is coordinator in international educational programs of European Master (i.e. European Master in Stroke Medicine, University of Krems), organizer and co-organizer of many educational projects: European and international schools and courses (International School of Neurology, European Stroke Organisation summer School, Danubian Neurological Society Teaching Courses, Seminars - Department of Neurosciences, European Teaching Courses on Neurorehabilitation) and scientific events: congresses, conferences, symposia (International Congresses of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN), International Association of Neurorestoratology (IANR) & Global College for Neuroprotection and Neuroregeneration (GCNN) Conferences, Vascular Dementia Congresses (VaD), World Congresses on Controversies in Neurology (CONy), Danube Society Neurology Congresses, World Academy for Multidisciplinary Neurotraumatolgy (AMN) Congresses, Congresses of European Society for Clinical Neuropharmacology, European Congresses of Neurorehabilitation).
His activity includes involvement in many national and international clinical studies and research projects, over 350 scientific participations as “invited speaker” in national and international scientific events, a significant portfolio of scientific articles (134 papers indexed on Web of Science-ISI, H-index: 15) as well as contributions in monographs and books published by prestigious international publishing houses. Prof. Dr. Dafin F. Muresanu has been honoured with: the Academy of Romanian Scientists, “Carol Davila Award for Medical Sciences / 2011”, for the contribution to the Neurosurgery book “Tratat de Neurochirurgie” (vol.2), Editura Medicala, Bucuresti, 2011; the Faculty of Medicine, University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj-Napoca “Octavian Fodor Award” for the best scientific activity of the year 2010 and the 2009 Romanian Academy “Gheorghe Marinescu Award” for advanced contributions in Neuroprotection and Neuroplasticity.
Dr Eddy Lang
Eddy Lang is the Academic and Clinical Department Head and a Professor of the Department of Emergency Medicine, at the Cumming School of Medicine, University of Calgary. He also holds the position of Senior Researcher with Alberta Health Services. He co-chaired the 2007 Academic Emergency Medicine Consensus Conference on Knowledge Translation which remains an ongoing interest. Dr. Lang is a member of the GRADE working group and has led the development of GRADE-based clinical practice guidelines in pre-hospital care in the US and is currently engaged in the same activity with the International Liaison Committee on Resuscitation. Dr. Lang is also an award-winning educator having received recognition at both the university, national and international levels. He also serves as Senior Associate Editor for the Canadian Journal of Emergency Medicine and Associate Editor for ACP Journal Club and the International Journal of Emergency Medicine. He also writes a quarterly column for the Calgary Herald on Evidence-Based Medicine.
Dr. Robyn Temple-Smolkin
Robyn is the Director of Clinical and Scientific Affairs at Association for Molecular Pathology (AMP). Robyn has a B.A. in Biology from State University of New York at Geneseo, NY and a Ph.D. in Molecular & Cellular Biology from State University of New York Health Science Center at Brooklyn, NY. Robyn has a background in molecular diagnostics and pathology, clinical laboratory compliance, process and quality management, and business development. During her career, Robyn has obtained multiple clinical certifications to include Technical Supervisor in Molecular Diagnostics (ABB), Qualification in Laboratory Compliance (ASCP), and Technologist in Molecular Biology (ASCP). She is board-certified as a High Complexity Laboratory Director in Molecular Diagnostics (ABB). Robyn has pursued post-graduate training in business administration and LEAN Six Sigma (Black Belt level). After fellowship in transplant immunogenetics at the University of Pittsburgh Medical Center, Robyn was a Clinical Molecular Diagnostics Specialist at Shodair Children’s Hospital Medical Genetics Department in Helena, MT where she developed and implemented a clinical pharmacogenetic testing program. She cofounded and was Director of Laboratory Operations of Big Sky Diagnostic Labs, a CAP-accredited CLIA-licensed independent molecular pathology laboratory focused on women's health and infectious disease. A member for over a decade, Robyn has served on the AMP Membership and Professional Development (Membership Affairs) and Nominating Committees. She joined AMP staff in 2014 as the Project Manager for Scientific and Clinical Programs, becoming Director of Clinical and Scientific Affairs later that year. In this role, Robyn is responsible for AMP’s Innovation and Improved Patient Care initiatives, which includes project management and strategic planning for AMP’s Clinical Practice Committee and all five scientific subdivisions.
As Director of Clinical and Scientific Affairs, Robyn has primary development and oversight responsibilities for clinical practice guideline activities at AMP. Recent projects include:
- Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline from the American Society of Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology (in press)
- Molecular Testing Guideline for Selection of Lung Cancer Patients: Guideline Update from the College of American Pathologists, International Association for the Study of Lung Cancer, and the Association for Molecular Pathology (in development)
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. Li, M.M. et al., The Journal of Molecular Diagnostics, Volume 19, Issue 1, 4 – 23, 2017.
- The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology. Joseph, L. et al., The Journal of Molecular Diagnostics, Volume 18, Issue 5, 605 – 619, 2016
Denny John, MBA, MPH, PT
Denny is currently working as Evidence Synthesis Specialist, GDN-Campbell Collaboration, at Global Development Network (GDN), New Delhi. He has experience of working with development organisations and consulting companies for conducting cost-effectiveness analysis, systematic reviews and epidemiological forecasting studies. He has experience of working in healthcare delivery and community health projects in India and Nepal, and provided technical support for projects in Bangladesh, Tanzania, and Nigeria. Denny has been the Principal Investigator/Co-Investigator for over 15 research studies conducted across various states in India, and has been awarded several research and project grants from national and international bodies.
Denny has published over 25 articles in peer-review journals, book chapters, and technical reports in the field of health financing, systematic reviews & meta-analysis, cost-effectiveness analysis, and implementation research. He is one of the co-authors of the first ‘Pharmacoeconomics and Outcomes Research Guidelines for India’, and currently collaborating with academics on developing ‘Economic Evaluation Guidelines for Vaccines in India’. He is a reviewer for International Journal for Technology Assessment in Healthcare, Value in Health-Regional Issues, Patient Experiences Journal, Medical Decision Making and reviews of the Cochrane Collaboration.
In addition to the above, Denny has a MBA in Hospital Management from Institute of Health Management Research (IIHMR), Jaipur, Master of Public Health (MPH) from University of Auckland, New Zealand, and Bachelor of Physiotherapy from Mangalore University. He is Fellow of Royal Society of Public Health, UK, and Royal Society of Tropical Medicine and Health, UK, and is the Chair-Elect for ISPOR Asia Young Professionals Group (2015-17).
Denny aims to spread the knowledge and build capacity towards evidence synthesis, and economic evaluation, and wider uptake of evidence-based health policy in developing countries such as India.
Dr Edgar Mora Brito
Dr. Edgar Mora Brito is a specialist in Internal Medicine and has a Diploma in Diabetes and Clinical Research Methodology. He is a winner of 4 awards of the specialty (Latin American Society of Internal Medicine, Ecuadorian Society of Endocrinology, International Diabetes Federation).
Edgar is the President of the Ecuadorian Diabetes Federation, regional Amazon, Director of Teaching and Research at General Puyo Hospital and a Physician Assistant, Teacher and Researcher.
He is also a delegate of the Latin American Diabetes Association (ALAD) Ecuador from 2013-2016.
Edgar has participated in the coordination of the process of adaptation of Clinical Practice Guidelines (CPG) for the Ministry of Public Health (MPH) of Ecuador. He has participated in the adaptation of the CPG of Gestational Diabetes, CPG of type 2 diabetes mellitus and CPG of Hypertension of MPH Ecuador.
His main lines of investigation include metabolic disorders and ethnicities, bioinformatic tools for improving care for chronic patients (Computerised System Development Support for Chronic Disease Management version 1.0 (2010-2013). adhap.hgp.gob.ec), diabetologica education, audit services in the field of chronic disease, epidemiology of chronic diseases, chronic disease and disability and diabetes prevalence in patients with tuberculosis.
Dr David Riley
David Riley MD is board certified in Internal Medicine and been a medical journal editor and writer since 1995.
He participated in the development of the CONSORT health research reporting guidelines from 2000 – 2004, and led the development of reporting guidelines for case reports—the CARE Guidelines in 2011. Systematic and transparent case reports can provide (1) early signals of effectiveness, harms and resource use; (2) inform clinical practice guidelines (CPGs) and (3) generate testable hypotheses for clinical research.
Health Quality Ontario
Health Quality Ontario (HQO) is the provincial advisor on the quality of health care. HQO reports to the public on the quality of the health care system, evaluates the effectiveness of new health care technologies and services, and supports quality improvement throughout the system.
Visit www.hqontario.ca for more information.
Marjan van den Akker, PhD
Marjan was trained as a health scientist and epidemiologist and is working as an associate professor at the departments of Family Medicine of Maastricht University (the Netherlands) and the Academic Center for General Practice of the KU Leuven (Belgium).
Her research activities focus on comorbidity, multimorbidity, polypharmacy, psychosocial profiles in longitudinal perspective and well-being of older cancer patients/survivors as well as the role of family medicine in the care for cancer survivors.
As a young researcher, her main focus of research was epidemiological studies on multimorbidity (prevalence and incidence of multimorbidity and associations with psychosocial characteristics, as well as descriptive studies of co-morbidity of chronic diseases). Increasingly, this incorporates more complex longitudinal epidemiological analyses of the development of multimorbidity and polypharmacy, disentangling morbidity and medication patterns. Furthermore, analyses focus on interactions (disease-disease, treatment-treatment, and treatment-disease), the feasibility of applying (disease specific) guidelines to patients who have multimorbidity, and incorporating patient preferences.
Current studies regarding multimorbidity and polypharmacy include epidemiological analyses of data from the Registration Network Family Practices (RNH) of the Department of Family Medicine Maastricht University, data from the Maastricht Aging Study (MAAS) of the Department of Psychiatry and Neuropsychology (Maastricht University) and data from the Intego database of the Academic Center for General Practice (KU Leuven); and an RCT evaluating a multidisciplinary intervention to optimise medication profiles in people using multiple chronic medication. New studies in this area are being planned.
Toju currently works as a Senior Research Analyst within the Infectious Disease Prevention and Control Branch of the Public Health Agency of Canada.
The focus of her work is writing evidence-based Infection Prevention and Control Guidelines. This involves public health research, critical review, critical appraisal, conducting systematic reviews, data and research analysis, evidence synthesis, scientific writing for guidelines and peer-reviewed publications, and knowledge transfer and exchange.
She works with the Agency’s Infection Prevention and Control Expert Working Group (with expertise in infectious disease, infection prevention and control, public health and occupational health) on the technical content for the guidelines. Toju's research experience is in microbiology, biotechnology, infection prevention and control, and synchrotron science. She has conducted research, data collection and/or analysis in academia, health and food industry and most recently, the federal government. She has a Masters’ degree in Microbiology from the University of Saskatchewan, Canada.
Amy is a Pediatric Physical Therapist at Lucile Packard Children's Hospital at Stanford for 10 years. She received her Masters of Science in Physical Therapy at UCSF in 2003 and received her Doctorate of Physical Therapy from Temple University in May 2013.
In addition, Amy is a credentialed Clinical Instructor for Physical Therapy Interns and is the Center Coordinator of Clinical Education for the physical therapy department. Clinically, Amy sees medically complex children of all ages in our outpatient physical therapy clinic. She recently became the primary PT in the multidisciplinary Epidermolysis Bullosa Clinic here at LPCH. In addition, she recently presented work at the Debra (Dystrophic Epidermolysis Bullosa Research Association) of America Care Conference in Texas on “Physical Therapy Tips for Patients with EB”.
Through this clinical work, Amy is working closely with Debra International to establish a “Guideline Development Group” for the creation of a Clinical Practice Guideline for the Physical Therapy Management of Patients with Epidermolysis Bullosa. Part of this work includes collaborating with the American Physical Therapy Association, Academy of Pediatric Physical Therapy Knowledge Broker Network.
Narayan Prabhu lyer, MBBS, MD, FAAP
Dr. lyer is an Assistant Professor of Clinical Pediatrics at University of Southern California Keck School of Medicine and an Attending Neonatologist at the Children's Hospital Los Angeles.
He studied Medicine in Kerala University, India in 1999 and then got Paediatric training at Cardiff University and Royal College of Paediatrics and Child Health in the United Kingdom. Dr lyer then completed Pediatric Residency and subsequently a Fellowship in Neonatal-Perinatal Medicine at the Case Western Reserve University, Cleveland, Ohio, USA. He currently practices as a Neonatologist and provide intensive care for sick newborn infants.
Dr lyer is interested in evidence synthesis and guideline production and implementation. Heis a member of the Document Development and Implementation Committee of the American Thoracic Society (ATS), Vice Chair of the Evidence Synthesis Methodology Working Group of ATS and more recently the GRADE working group. Dr lyer’s research goal is to optimise guideline development process such that it is more efficient and the final guideline is easy for clinicians to implement.
International Centre for Allied Health Evidence (iCAHE)
iCAHE has its genesis in improving health and safety of allied health care.
Its mission is to contribute to better health and wellbeing for all through evidence-based allied health care. iCAHE works locally, nationally and globally to create new knowledge and translate evidence into safe, quality health care practices. iCAHE researchers partner with other researchers, cinicians, educators, policy makers, government, industry, professional and consumer groups and the broader community.
iCAHE has developed a wide range of tools, services and resources to support health practitioners, service managers, policy makers, consumer representatives and researchers translate evidence into policy and practice.
The iCAHE director is Professor Karen Grimmer (firstname.lastname@example.org). iCAHE currently has 66 members, comprising University of South Australia School of Health Science employees, externally-funded project researchers , and higher degree research students (Masters and PhD). iCAHE comprises ten core research areas (methods, implementation science, consumer engagement, cardiothoracic, musculoskeletal, teaching and learning, stroke and rehabilitation, early childhood development, medical radiations, and professional development and training).
Enquiries can be directed to Janice Kooymans at email@example.com (+61 8 83022072)
Dr Samantha L Wood, MD, FAAEM, FACEP
Dr. Wood is an Assistant Professor of Emergency Medicine at Tufts University School of Medicine and an Attending Physician in Emergency Medicine at Maine Medical Center in Portland, Maine. She studied at Yale University School of Medicine and completed a combined Emergency Medicine/Internal Medicine/Critical Care residency and fellowship at the University of Maryland School of Medicine. She is board certified in Emergency Medicine, Internal Medicine, and Critical Care.
Dr. Wood has been involved in creation and revision of guidelines and protocols at Maine Medical Center including several ED observation unit pathways, a sepsis guideline, and an atrial fibrillation guideline. She looks forward to membership in G-I-N as a resource and community as she continues to learn about and collaborate on guideline development at her institution.
Dr Tammy Clifford is the Vice President of CADTH’s Medical Device and Rapid Response Programs. Over the past decade, she has served in a number of senior leadership roles at CADTH, with responsibility for the agency’s Health Technology Assessment (HTA), Horizon Scanning, Rapid Response, Scientific Advice and Patient Engagement programs.
Tammy received her PhD in Epidemiology & Biostatistics at the University of Western Ontario, and her BSc and MSc from McGill. Through her role as an adjunct professor with the School of Epidemiology, Public Health & Preventive Medicine at the University of Ottawa, Tammy is building awareness of and capacity in HTA through her active involvement with the graduate program where she both teaches and supervises MSc and PhD students. She has been actively involved with national and international HTA activities, including having served on the Board of Directors of Health Technology Assessment international (HTAi), the international society for the promotion of HTA, and having participated in the development of the scientific programmes for many HTAi annual meetings.
Tammy is internationally recognised for her passion and commitment to advancing the science of HTA, and to mentoring the next generation of HTA producers.
Kathleen L Irwin, MD, MPH, FACPM, FIDSA
Leader, Guideline Development, Division of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
Dr. Irwin has dedicated her career to public health, preventing infectious diseases, and promoting women’s health. Since 2015, she has led development of guidelines about preventing healthcare-associated infections and antimicrobial drug resistance in CDC’s Division of Healthcare Quality Promotion in Atlanta. She has also served as leader of guideline development in CDC’s Division of HIV Prevention (2011-2015) and Chief of Health Services Research and Evaluation in CDC’s Division of STD Prevention (1998-2005) where she developed guidance on HIV and STD screening and treatment. From 2006-2011, she developed global HPV vaccine recommendations and evaluated adolescent vaccination programs at World Health Organisation in Switzerland and International Agency for Research on Cancer in France.
She has served on several national and international committees that developed clinical practice guidelines and advised the National Institutes of Health, the Health Resources and Services Administration, the US Agency for International Development, and other governmental and nongovernmental organisations. She has served as principal investigator on several studies about STD, HIV, and cancer prevention and has published extensively on these topics in peer-review journals. She also practiced primary care at Grady Hospital Clinics and served as Adjunct Associate Professor at Emory University’s School of Public Health. She is a Fellow of the Infectious Disease Society of America and board certified in Preventive Medicine and Public Health. She received a B.S. from Brown University, a MD from Boston University, and a MPH from University of Washington.
Jaqueline Carmona, was born in Germany in 1975, and lived some years in Switzerland. She is at the third year studying as a PhD Student - Science Cognition and Language at Portuguese Catholic University - Institute of Health Sciences. In 2008, Jaqueline was the European Clinical Specialisation in Fluency Disorders, coordinator of the postgraduation at Thomas More University College. She has a degree in Speech and Language Therapy from School of Health in higher education at Alcoitão (ESSA) and another degree in Linguistics from the Faculty of Social and Human Sciences from the New University of Lisbon.
Jaqueline currently practices as a Speech and Language Therapist at PIN, a Clinic near Lisbon. She is an invited lecturer at the School of Health in higher education at Alcoitão since 2003 and since 2010 has lectured on the discipline of Fluency Disorders. In addition to the Jaqueline represents the partner School in Higher Education ESSA, Portuguese partner at the European Clinical Specialisation in Fluency Disorders, lectures ‘Causal & Mantaining variables of stuttering’ and is also a mentor or coach of Speech and Language Therapists that carry out this graduation.